91 related articles for article (PubMed ID: 32027982)
21. Immunohistochemical analysis of Ku70/86 expression of breast cancer tissues.
Someya M; Sakata K; Matsumoto Y; Satoh M; Narimatsu H; Hareyama M
Oncol Rep; 2007 Dec; 18(6):1483-7. PubMed ID: 17982634
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
[TBL] [Abstract][Full Text] [Related]
23. Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism.
Cosaceanu D; Budiu RA; Carapancea M; Castro J; Lewensohn R; Dricu A
Oncogene; 2007 Apr; 26(17):2423-34. PubMed ID: 17043647
[TBL] [Abstract][Full Text] [Related]
24. Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy.
Friesland S; Kanter-Lewensohn L; Tell R; Munck-Wikland E; Lewensohn R; Nilsson A
Head Neck; 2003 Apr; 25(4):313-21. PubMed ID: 12658736
[TBL] [Abstract][Full Text] [Related]
25. The truncation of Ku86 in human lymphocytes.
Łanuszewska J; Widłak P
Cancer Lett; 2004 Mar; 205(2):197-205. PubMed ID: 15036652
[TBL] [Abstract][Full Text] [Related]
26. Rad52 competes with Ku70/Ku86 for binding to S-region DSB ends to modulate antibody class-switch DNA recombination.
Zan H; Tat C; Qiu Z; Taylor JR; Guerrero JA; Shen T; Casali P
Nat Commun; 2017 Feb; 8():14244. PubMed ID: 28176781
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
[TBL] [Abstract][Full Text] [Related]
28. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
29. Role of human Ku86 in telomere length maintenance and telomere capping.
Jaco I; Muñoz P; Blasco MA
Cancer Res; 2004 Oct; 64(20):7271-8. PubMed ID: 15492246
[TBL] [Abstract][Full Text] [Related]
30. Ku86 alleviates human umbilical vein endothelial cellular apoptosis and senescence induced by a low dose of ionizing radiation.
Wu K; Chen Z; Peng Q; Chen G; Yan W; Chen X
J Int Med Res; 2019 Feb; 47(2):893-904. PubMed ID: 30616437
[TBL] [Abstract][Full Text] [Related]
31. Regulation of telomere length and suppression of genomic instability in human somatic cells by Ku86.
Myung K; Ghosh G; Fattah FJ; Li G; Kim H; Dutia A; Pak E; Smith S; Hendrickson EA
Mol Cell Biol; 2004 Jun; 24(11):5050-9. PubMed ID: 15143195
[TBL] [Abstract][Full Text] [Related]
32. The 3D solution structure of the C-terminal region of Ku86 (Ku86CTR).
Harris R; Esposito D; Sankar A; Maman JD; Hinks JA; Pearl LH; Driscoll PC
J Mol Biol; 2004 Jan; 335(2):573-82. PubMed ID: 14672664
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization effects of berberine on human breast cancer cells.
Wang J; Liu Q; Yang Q
Int J Mol Med; 2012 Nov; 30(5):1166-72. PubMed ID: 22895634
[TBL] [Abstract][Full Text] [Related]
34. Impaired telomerase activity in human cells expressing GFP-Ku86 fusion proteins.
Badie C; Yáñez-Muñoz RJ; Muller C; Salles B; Porter AC
Cytogenet Genome Res; 2008; 122(3-4):326-35. PubMed ID: 19188702
[TBL] [Abstract][Full Text] [Related]
35. Restoration of X-ray and etoposide resistance, Ku-end binding activity and V(D) J recombination to the Chinese hamster sxi-3 mutant by a hamster Ku86 cDNA.
He DM; Lee SE; Hendrickson EA
Mutat Res; 1996 May; 363(1):43-56. PubMed ID: 8632777
[TBL] [Abstract][Full Text] [Related]
36. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
Ayene IS; Ford LP; Koch CJ
Mol Cancer Ther; 2005 Apr; 4(4):529-36. PubMed ID: 15827325
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning, genomic characterization and over-expression of a novel gene, XRRA1, identified from human colorectal cancer cell HCT116Clone2_XRR and macaque testis.
Mesak FM; Osada N; Hashimoto K; Liu QY; Ng CE
BMC Genomics; 2003 Aug; 4(1):32. PubMed ID: 12908878
[TBL] [Abstract][Full Text] [Related]
38. Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability.
Snijders AM; Hermsen MA; Baughman J; Buffart TE; Huey B; Gajduskova P; Roydasgupta R; Tokuyasu T; Meijer GA; Fridlyand J; Albertson DG
Genes Chromosomes Cancer; 2008 Jan; 47(1):71-83. PubMed ID: 17943968
[TBL] [Abstract][Full Text] [Related]
39. Senescent human fibroblasts have elevated Ku86 proteolytic cleavage activity.
Jeng YW; Chao HC; Chiu CF; Chou WG
Mutat Res; 1999 Dec; 435(3):225-32. PubMed ID: 10606813
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
